SCP
CCEL icon

Seizert Capital Partners’s Cryo-Cell International CCEL Stock Holding History

Seizert Capital Partners’s Portfolio CCEL Stock Details CCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-43,483
Closed -$332K – 204
2022
Q1 		$332K Hold
43,483
– – 0.02% 185
2021
Q4 		$504K Hold
43,483
– – 0.02% 175
2021
Q3 		$527K Buy
+43,483
New +$536K 0.02% 167

Other funds holding CCEL

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
SA
SFI Advisors Montclair, New Jersey $95.2M AUM 23.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MCM
Maryland Capital Management Towson, Maryland $1.2B AUM 18.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Seizert Capital Partners's CCEL Position: Q2 2022 in Review

Seizert Capital Partners sold out of Cryo-Cell International (CCEL) in Q2 2022, closing a stake of 43,483 shares — an estimated $332K sold.

Seizert Capital Partners first reported a position in CCEL in Q3 2021 and held it in 3 quarters. The position peaked at $527K in Q3 2021. 13 funds tracked by Wall St. Rank hold CCEL as of Q2 2022.

  • Seizert Capital Partners reported no remaining Cryo-Cell International position as of Q2 2022 after selling out during the quarter.
  • Seizert Capital Partners sold 43,483 Cryo-Cell International shares in Q2 2022, an estimated $332K.
  • Seizert Capital Partners first reported a position in Cryo-Cell International in Q3 2021 and held it in 3 quarters.
  • Seizert Capital Partners's Cryo-Cell International position peaked at $527K in Q3 2021.
  • 13 funds tracked by Wall St. Rank held Cryo-Cell International as of Q2 2022.

Based on Seizert Capital Partners's 13F filing for Q2 2022, filed 4 Aug 2022.